Potential of Substance P Antagonists as Antiemetics

ISSN： 0012-6667

Source： Drugs, Vol.60, Iss.3, 2000-09, pp. : 533-546

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Substance P Receptor Antagonists in Psychiatry: Rationale for Development and Therapeutic Potential

By Herpfer Inga Lieb Klaus

CNS Drugs, Vol. 19, Iss. 4, 2005-01 ,pp. : 275-293

Adis International

Access to resources Recommend Favorite

Substance P receptor antagonists in the therapy of migraine

By May A. Goadsby P.J.

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 4, 2001-04 ,pp. : 673-678

Informa Healthcare

Access to resources Recommend Favorite

Substance P antagonists: novel agents in the treatment of depression

By Argyropoulos S.V. Nutt D.J.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 8, 2000-08 ,pp. : 1871-1875

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic potential of NMDA receptor antagonists in the treatment of alcohol and substance use disorders

By Bisaga A. Popik P. Bespalov A.Y. Danysz W.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 10, 2000-10 ,pp. : 2233-2248

Informa Healthcare

Access to resources Recommend Favorite

NK 1 (substance P) receptor antagonists - why are they not analgesic in humans?

By Hill R.

Trends in Pharmacological Sciences, Vol. 21, Iss. 7, 2000-07 ,pp. : 244-246

Elsevier

Access to resources Recommend Favorite